Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased
thromboembolic risk. The impact of the female sex as an independent risk factor for …

Studies comparing gender-specific outcomes in patients with atrial fibrillation (AF) have
reported conflicting results. Gender differences in cerebrovascular accident/systemic …

Background—Among patients with atrial fibrillation (AF), women are at higher risk of stroke
than men. Using prospective cohort data from a large global population of patients with …

Background: Gender is a well-recognized risk factor in atrial fibrillation (AF)-related ischemic
stroke. The association of gender with the use of oral anticoagulants (OACs) and prognosis …

Sex and gender differences have been reported in atrial fibrillation (AF), especially in
relation to differences in thromboembolic and bleeding risks. More recently …

ABSTRACT Background and Objectives: In patients with atrial fibrillation (AF), females
taking vitamin K antagonist are at higher risk of stroke or systemic embolism (SSE), bleeding …

Sex‐specific differences have been definitively demonstrated in cardiovascular (CV)
diseases. These differences can also impact on the effects of CV therapies. Female sex is …

Background: Female sex has been suggested as a risk factor for stroke/thromboembolism in
patients with non‐valvular atrial fibrillation (AF) and has therefore been included within risk …

Aims Data on gender differences in oral anticoagulation for stroke prevention in patients with
atrial fibrillation are conflicting, largely limited to regional reports and vitamin K antagonist …

Atrial fibrillation (AF) is the most common clinically relevant arrhythmia and increases the
risk of thromboembolism and stroke; however, these risks are not the same for women and …